IDEX Biometrics Completes First Tranche of Share Placement
IDEX Biometrics ASA has taken a significant step by successfully completing the first phase of its private placement, generating gross proceeds of NOK 70 million. This marks an exciting chapter for the company as it continues to innovate in the realm of biometric solutions.
Private Placement Structure Overview
The private placement comprises two key segments. In Tranche 1, IDEX allocated a total of 101,624,966 shares, known as Tranche 1 Offer Shares. The second tranche includes a larger allocation of 365,041,700 Offer Shares. For both tranches to proceed smoothly, it's vital that the Company’s Board of Directors obtains appropriate authorization.
Important Dates and Board Resolutions
The Board of Directors secured the required authorization during an Extraordinary General Meeting that took place on 23 September. Following that meeting, on 25 September, they resolved to issue the Tranche 1 Offer Shares as a fundamental part of their growth strategy.
Next Steps for Tranche 2
Looking forward, shareholders will have the chance to vote on the approval for Tranche 2 at an Extraordinary General Meeting scheduled for 9 October. Securing this approval is essential for further enhancing IDEX Biometrics’ capital structure.
Impact of Share Capital Increase
With the registration of the capital increase tied to Tranche 1, IDEX Biometrics will see its total share capital grow to NOK 66,056,228.10. This will be divided among 440,374,854 shares, with each share having a nominal value of NOK 0.15.
Future Outlook and Market Position
IDEX Biometrics ASA is recognized as a frontrunner in technology innovation, particularly in fingerprint biometrics. Their products are crucial for improving secure transactions, identity verification, and access control across a variety of applications. The company has formed partnerships with reputable card manufacturers and tech firms, delivering advanced authentication solutions that enhance user experiences while ensuring maximum security.
Dedication to Innovation
At the heart of IDEX Biometrics' mission lies a commitment to innovation. The company utilizes proprietary sensor technologies and software to develop user-friendly solutions for payment processing and digital authentication.
Significance of Compliance
Compliance with regulatory standards is vital for IDEX Biometrics, as highlighted by their adherence to section 5-12 of the Norwegian Securities Trading Act. This commitment underscores the transparency and accountabilities of their operations, fostering trust among stakeholders.
Frequently Asked Questions
What is the purpose of the private placement by IDEX Biometrics?
The aim of the private placement is to raise funds essential for supporting the company’s growth and innovation in biometric solutions.
How many shares were allocated in Tranche 1?
IDEX Biometrics allocated 101,624,966 shares in the first tranche.
When is the Extraordinary General Meeting for Tranche 2?
The Extraordinary General Meeting for Tranche 2 will take place on 9 October.
Who can be contacted for further information about the company?
For additional information, please reach out to Marianne Bøe, Head of Investor Relations, via email or phone.
What is the nominal value of the company's shares after the capital increase?
Following the capital increase, each share has a nominal value of NOK 0.15.
